Most, if not all, ingested protein is degraded into amino acids, which are then absorbed. Absorption of amino acids has been studied in intact animals, everted gut sacs, and in other preparations of intestine. These studies have been reviewed recently (1, 2). Comparatively little is known, however, about amino acid absorption in the human. Kuroda and Gimbel (3) showed that when racemic amino acids were placed in the isolated ileal loop of a patient operated on for ulcerative colitis, the L-isomer disappeared faster than the D-isomer. Cummins (4) reported a directly proportional increase in the amount of DLmethionine that disappeared from a length of gut when the concentration of the amino acid was doubled. The kinetics of absorption of L-methionine at various sites in the human small intestine were determined by Schedl and Clifton (5). The uptake of certain amino acids by human intestinal biopsy specimens is dependent, at least in part, on active transport (6, 7). This report presents results of studies on absortion of glycine and L-alanine in human subjects. These amino acids were chosen for study because considerable information is available about their absorption by in vitro preparations. Glycine and L-alanine in man appear to be absorbed by active transport processes and to share a common absorptive pathway for which L-alanine has greater affinity. These findings agree with the results of studies in tissue preparations. 
Methods
Studies were performed in three normal adult male subjects. Fifty-five separate studies were carried out: 25 in the first, 21 in the second, and 9 in the third subject. Each individual was intubated with a tube assembly consisting of two polyvinyl tubes joined along their lengths by a solvent, tetrahydrofuran. One tube had an inlet (perfusion opening) that was 15 cm proximal to the distal recovery opening in the other tube. The sites of the openings were marked with mercury, and the tube position was identified at the beginning and end of each study by image intensifier fluoroscopy. The perfusion opening was positioned just distal to the duodenojejunal junction and repositioned at this site at the start of each study. Tube progression during each study was minimal, and the tip never passed farther than one jejunal loop. The subjects tolerated the tube in place for 3 to 4 days and continued to eat and to maintain normal ward activity. The tube was then removed and the cycle begun again after an interval of at least 3 days.
Each study was done in the morning after an overnight fast during which water intake was permitted. The studies were performed as "steady state" experiments with the jejunal segment constantly perfused with the same solution. Perfusion was done with a peristaltic pump 1 set to deliver at a constant rate of 12 ml per minute, and the amount of fluid delivered during each period was measured. Recovery of the fluid from the opening 15 cm distal to the perfusing site was maintained by siphonage. The aspirate was collected in ice and frozen until analysis. Each study began with a 30-minute equilibration period in which the test solution was perfused and the intestinal contents were aspirated. Although the analyses of these initial aspirates yielded results generally similar to those of the later periods, they are not included in this report. Perfusion was continued after the equilibration period with constant aspiration. Ex- perimental aspirates were collected for six successive 15-minute periods for Subjects 1 and 2 and for four periods for Subject 3; each aspirate was analyzed separately.
The perfusion solution contained 0.5 g per 100 ml of polyethylene glycol (PEG) ,2 a nonabsorbable reference marker having a molecular weight of 3,000 to 3,700; 1Harvard Apparatus Co., Dover, Mass. 2 Matheson, Coleman and Bell, Norwood, Ohio,
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either glycine 3 or L-alanine 3 or a mixture of the two; and sufficient NaCl to make the final osmolality approximately 300 mOsm per kg. In one study mannitol was substituted for sodium chloride. Only one perfusate was tested each study day. Using the instruments and methods indicated, we determined the following for each perfusate and for the aspirates collected during each 15-minute period: volume (milliliters), pH (units) ,4 osmolality by freezing point depression (milliosmoles per kilogram),5 PEG concentration (milligrams per 100 ml) (8), sodium concentration (milliequivalents per liter) on a Baird clinical photometer,6 a-amino nitrogen (milligrams per milliliter) by the copper-complexing method modified by Kekki (9) , and amino acid concentration (millimoles per liter) by column chromatography according to modifications of the method of Spackman, Stein, and Moore (10, 11) of PEG in the perfusate and aspirate. This calculation assumes that PEG truly is a nonabsorbable reference marker. PEG has been used in similar experiments, and the assumption appears justified, at least for water soluble substances such as the amino acids used in this study (14) . The average amount of PEG recovered in the present study was 36% with a range of 12 to 75%. The presence of endogenous amino acids in the gut lumen could also affect the accuracy of the calculation, but the data to be reported indicate that little con- (Table II) . The a-amino nitrogen content of the perfusates calculated from the amounts of amino acids contained was compared with the a-amino nitrogen content test further the competition between glycine and L-alanine, we perfused the two together at varying concentrations of each. A level of L-alanine was sought that permitted studies to be performed with varying glycine concentrations but with the total osmolality maintained at 300 mOsm per kg. On the basis of these preliminary experiments, an L-alanine concentration of 150 mmoles per LJ was chosen. The results of simultaneous perfusion of L-alanine (150 mmoles per L) with varying glycine concentrations are shown in Table IV . At each perfusate, concentration of glycine the amount absorbed was less than the amount absorbed when glycine was perfused alone (Table  III) . Over the range of glycine concentrations tested (25 to 150 mmoles per L), no inhibition of L-alanine absorption was found when the data for L-alanine perfused with glycine (Table IV) were compared with the data for L-alanine perfused alone at the same concentration, 150 mmoles per L (Table III) . Absorption of L-alanine was less in both subjects, however, at the highest glycine concentration tested (150 mmoles per L) compared with the lowest (25 mmoles per L). These differences, in all probability, represent day-to-day Discussion "Absorption" as used in this report refers to the disappearance of the amino acid from the jejunal segment tested. The absorptive process involves a series of sequential steps including entry into the cell; transport or metabolism within the cell, or both; and exit into either blood or lymph. The kinetic data presented are consistent with the idea that at least part of the process may be dependent upon active transport. Active transport processes may be demonstrated by inhibition of transport by interference with the energy balance of the cell and by accumulation of substrate against a concentration gradient (20). In the present study, information regarding the latter way of demonstrating active transport was gathered. The intracellular concentration of either gly-cin or L-alanine was not known. Thus, strictly, accumulation against a concentration gradient could not be demonstrated. However, absorption of either amino acid rose as the concentration in the perfusate was increased but tended to approach a limiting value as the ratelimiting mechanism became saturated. This is the observed relationship when active transport processes are involved. Competitive inhibition, although consistent with an active transport process, does not necessarily imply such a process, since in facilitated diffusion such inhibition may also occur. In this study L-alanine (150 mmoles per L) inhibited the absorption of glycine. The inhibition was competitive in type since with increasing concentration glycine absorption not only increased but approximated the theoretical maximal absorptive rates (Vmax) found when glycine alone was perfused. If the observed inhibition were noncompetitive in nature, seen when substances such as phlorizin are used, absorption might increase with increasing substrate concentrations but would not approach maximal absorptive rates. Glycine and L-alanine thus appear to be absorbed, at least in part, by the same ratelimiting mechanism. These findings in humans agree with those in other species (16, 17, 21) .
Kinetic constants, as calculated in this report and by others, are useful methods of comparing the absorption of various amino acids. The constants derived from our data for human subjects certainly are not definitive, but they are of the same order of magnitude as those for hamster everted gut sacs (16, 17) and for the isolated rat intestine (21) where the models are less physiologic but better control is possible. Furthermore, the constants determined for L-alanine were lower than those for glycine in all studies. The The hypothesis has been advanced that the lipid rich cell membrane shows increased affinity for amino acids with more lipophilic side chains (21, 22) . Thus, L-alanine, with a longer side chain than glycine, would have greater affinity for the absorptive mechanism. Increased affinity usually is associated with lower Km. The competitive effect of L-alanine on glycine absorption and the lower Km observed for L-alanine than for glycine in our studies are consistent with such postulates.
The validity of the conclusions discussed above depends, in part, on the degree to which the experimental situation corresponded to a true steady state. Changes in osmolality of the aspirates compared with the perfusate, although statistically significant, were small, and pH was relatively stable. Although endogenous amino acids may be found in the gut lumen when protein or amino acid mixtures are fed (23) , under the conditions of this study no amino acids were found other than those perfused, and the total a-amino nitrogen content was accounted for by the known amino acids. Thus, it appears reasonable to utilize these data as indicated above.
In the human, unlike results of in vitro experiments, sodium need not be supplied in the perfusate for amino acid absorption to occur. The role of sodium in absorption of amino acids has been considered crucial, though not necessarily specific. Csaky reported significant diminution in active transport by the isolated frog small intestine when lithium or potassium was substituted for sodium as the major cation in the bathing solution (24) . The transport of the amino acids L-tyrosine and DL-phenylalanine, the sugar 3,methylglucose, and the pyrimidine uracil were all greatly inhibited under these circumstances. Similar results were reported for the transport of L-tyrosine by the rat everted small intestine (25) and for the transport of glycine, methionine, and a model amino acid by both rat and rabbit jejunal sacs (26) . In contrast, amino acid absorption in our subjects was not affected by large variations in the sodium content of the perfusing fluid. Even when no sodium was present, as in experiments when amino acid concentration was 300 mmoles per L, absorption occurred. Furthermore, when mannitol was substituted for NaCl with 75 mM glycine, absorption was similar to that found when NaCl was used in the perfusing fluid. Sodium, presumably as NaCl. was consistently supplied to the gut contents as a mole-for-mole replacement of absorbed amino acid.
The movement of NaCl into the lumen may be secondary to the absorption of amino acid and has the effect of maintaining the isosmolarity of the jejunal fluid despite changes in the concentration of solutes involved. These data do not indicate that sodium is unnecessary for amino acid absorption in the human. The concentration required probably is quite low, and endogenous sodium may be present in sufficient amounts.
Information as to the variation when a single amino acid concentration is perfused in the same subject on separate days was not obtained. The geometric mean concentration of perfused and recovered L-alanine, 150 mmoles per L, was remarkably stable whether L-alanine was perfused alone or with glycine, although the absorption of L-alanine at this concentration when perfused with differing concentrations of glycine varied from one test day to another. Several factors may be involved in such variation, but the finding that the absorption data in this study were so similar for the subjects tested and could be plotted along a straight line by the Lineweaver-Burk method indicates that the amount of variation was reasonably low.
A variety of problems are involved in studying the kinetics of absorption in man. Simply placing a tube into the gut for lengthy periods and performing repetitive studies in the same subject necessitates considerable patience on the part of both subject and investigator. It is difficult to be certain that exactly the same segment is being tested from day to day since the relation of gut segment to tube may change in an unpredictable fashion. Furthermore, the extent to which the dynamic processes taking place during absorption vary from time to time and subject to subject is unknown. Despite these difficulties, the studies presented demonstate that approximations of steady state conditions can be obtained and that sufficient intra-and inter-subject reproducibility exists to permit tentative conclusions to be drawn concerning the absorption of glycine and L-alanine in the human jejunum.
Summary
Glycine and L-alanine absorption from the human jejunum was investigated by a "steady state" perfusion technique. Perfusates for jejunal intubation contained either glycine or L-alanine, or both, the nonabsorbed indicator, polyethylene glycol, and sufficient sodium chloride so that osmolality approximated 300 mOsm per kg. Aspirates were obtained continuously by siphonage from a site 15 cm distal to the perfusing site. Osmolality of the aspirates fell only slightly, and pH rose minimally as compared with the perfusion solutions. a-Amino nitrogen content of the aspirates was accounted for by the amounts of perfused amino acids recovered, indicating that the test segment contained no significant quantity of endogenous amino acid. Amino acid absorption was not impaired either by the deletion of sodium from the perfusates or the substitition of mannitol for sodium chloride. A sodium compound, presumably sodium chloride, entered the gut lumen as a replacement for absorbed amino acid on a mole-for-mole basis, maintaining the isosmolalitv of the lumenal contents.
Absorption of either glycine or L-alanine increased as its concentration in the perfusate was raised, but the increase was not directly proportional over the range tested and approached a limiting value. Kinetic constants were calculated by the Lineweaver-Burk method. In two subjects, apparent Michaelis constants were 75 and 77 mmoles per L for glycine and 34 and 38 mmoles per L for L-alanine. Corresponding apparent maximal velocities (in millimoles per 15 minutes per 15-cm gut segment) were 13 and 16 for glycine and 12 and 18 for L-alanine. At equimolar concentrations ranging from 50 to 300 mmoles per L, L-alanine absorption always exceeded that of glycine when the two were perfused together. When varying concentrations of glycine were perfused at a constant L-alanine concentration of 150 mmoles per L, glycine absorption decreased in a manner suggestive of competitive inhibition.
These findings in humans are consistent with published data derived from in vitro studies which indicate that glycine and L-alanine are absorbed by active transport processes and that they share a rate-limiting step for which L-alanine has greater affinity.
